Madrigal Pharmaceuticals, Inc. (MDGL)
432.83
-6.51
(-1.48%)
USD |
NASDAQ |
Mar 06, 16:00
430.20
-2.63
(-0.61%)
After-Hours: 20:00
Madrigal Pharmaceuticals SG&A Expense (TTM) : 813.83M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Insmed, Inc. | 701.17M |
| Pfizer Inc. | 13.79B |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Eli Lilly & Co. | 11.09B |
| Johnson & Johnson | 23.68B |